Last $6.90 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 05/15/13 All times are local (Market data is delayed by at least 15 minutes).

abcam plc-unsp adr (ABCZY) Snapshot

Open
$6.90
Previous Close
$6.90
Day High
$6.90
Day Low
$6.90
52 Week High
05/3/13 - $7.24
52 Week Low
01/29/13 - $6.35
Market Cap
1.4B
Average Volume 10 Days
696.8
EPS TTM
--
Shares Outstanding
199.3M
EX-Date
03/20/13
P/E TM
--
Dividend
$0.06
Dividend Yield
1.43%
Current Stock Chart for ABCAM PLC-UNSP ADR (ABCZY)

Related News

No related news articles were found.

abcam plc-unsp adr (ABCZY) Related Businessweek News

No Related Businessweek News Found

abcam plc-unsp adr (ABCZY) Details

Abcam plc engages in the production and distribution of antibodies and related protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, tools and reagents, and immunoassays. Its products are used in the areas of cancer, cardiovascular, cell biology, epigenetics and nuclear signaling, developmental biology, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company sells its products primarily through the Internet. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.

680 Employees
Last Reported Date: 03/5/13
Founded in 1998

abcam plc-unsp adr (ABCZY) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: 394.0K GBP
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: 343.0K GBP
Chief Operating Officer, Managing Director an...
Total Annual Compensation: 369.0K GBP
Compensation as of Fiscal Year 2012.

abcam plc-unsp adr (ABCZY) Key Developments

Abcam Plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2012; Announces Interim Dividend for the Six Months Ended December 31, 2012, Payable on April 19, 2013; Provides Tax Rate Guidance for the Year 2013

Abcam Plc reported unaudited consolidated earnings results for the six months ended December 31, 2012. For the period, the company reported revenue from continuing operations of £57,330,000 against £44,679,000 a year ago. Operating profit was £19,924,000 against £16,911,000 a year ago. Profit before tax was £19,918,000 against £17,183,000 a year ago. Profit for the year attributable to shareholders was £15,160,000 or 7.57 pence per diluted against £12,901,000 or 6.97 pence per diluted share a year ago. Adjusted operating profit was £21,755,000 against £17,292,000 a year ago. Adjusted profit before tax was £21,749,000 against £17,564,000 a year ago. Adjusted profit after tax was £16,434,000 against £13,208,000 a year ago. Adjusted diluted EPS was 8.21 pence against 7.13 pence a year ago. Net cash inflow from operating activities was £18,278,000 against £13,706,000 a year ago. Purchase of property, plant and equipment was £2,020,000 against £746,000 a year ago. Purchase of intangible assets was £1,235,000 against £55,000 a year ago. The company announced a 14.8% increase in the interim dividend to 1.94 pence per share against 1.69 pence per share a year ago, which is in line with the increase in the adjusted diluted EPS. It is company's policy to distribute as dividend 40% of the full year's post-tax profit. The dividend is payable on 19 April 2013 to shareholders whose names are on the register at close of business on March 22, 2013. The company provided tax rate guidance for the year 2013. The average annual effective tax rate is expected to be 24.4% for the adjusted profit against 24.8% in 2011/12 and 23.9% for the reported IFRS profit against 24.9% in 2011/12.

Abcam Plc to Report First Half, 2013 Results on Mar 05, 2013

Abcam Plc announced that they will report first half, 2013 results on Mar 05, 2013

Abcam Plc, H1 2013 Earnings Call, Mar 05, 2013

Abcam Plc, H1 2013 Earnings Call, Mar 05, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABCZY:US $6.90 USD 0.00

ABCZY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $3.69 USD -0.02
Enzo Biochem Inc $2.28 USD +0.03
GW Pharmaceuticals PLC 51.00 GBp +2.63
Sinclair IS Pharma PLC 28.13 GBp +0.25
Techne Corp $67.74 USD +0.24
View Industry Companies
 

Industry Analysis

ABCZY

Industry Average

Valuation ABCZY Industry Range
Price/Earnings 30.0x
Price/Sales 7.6x
Price/Book 5.4x
Price/Cash Flow 30.5x
TEV/Sales 7.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABCAM PLC-UNSP ADR, please visit www.abcam.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.